Literature DB >> 3040504

Protein kinase C in the regulation of smooth muscle contraction.

H Rasmussen, Y Takuwa, S Park.   

Abstract

The cellular and molecular mechanisms underlying smooth muscle contraction are reviewed in the light of recent studies of smooth muscle ultrastructure and of the role of polyphosphoinositide turnover and protein kinase C function in smooth muscle contraction. A new model of smooth muscle contraction is proposed that differs radically from accepted views, particularly the latch bridge hypothesis, in terms of both Ca2+ messenger function and the molecular events underlying this process. A coordinate fibrillar domain model of contraction is proposed in which the initial and sustained phases of contraction are mediated by different cellular and molecular events. The initial phase of response is mediated by a rise in [Ca2+]c and the resulting calmodulin-dependent activation of both myosin light chain kinase and the dissociation of caldesmon from the actin-caldesmon-tropomyosin-myosin fibrillar domain. These events lead to an interaction between actin and the phosphorylated light chains of myosin just as in previous models. However, this initial phase is followed by a sustained phase in which a rise in [Ca2+]sm stimulates the plasma membrane-associated, Ca2+-sensitive form of protein kinase C that results in the phosphorylation of both structural and regulatory components of the filamin-actin-desmin fibrillar domain. These events underlie the tonic phase of contraction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040504

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  76 in total

Review 1.  Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis.

Authors:  B L Webb; S J Hirst; M A Giembycz
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Remodeling of the actin cytoskeleton in the contracting A7r5 smooth muscle cell.

Authors:  M E Fultz; C Li; W Geng; G L Wright
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

Review 4.  What is latch? New ideas about tonic contraction in smooth muscle.

Authors:  S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1989-04       Impact factor: 2.698

5.  A major role for the rho-associated coiled coil forming protein kinase in G-protein-mediated Ca2+ sensitization through inhibition of myosin phosphatase in rabbit trachea.

Authors:  K Iizuka; A Yoshii; K Samizo; H Tsukagoshi; T Ishizuka; K Dobashi; T Nakazawa; M Mori
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

6.  A tight-binding interaction between smooth-muscle native thin filaments and heavy meromyosin in the presence of MgATP.

Authors:  S B Marston
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 7.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

8.  Ca(2+) entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes.

Authors:  Fabio Fusi; Simona Saponara; Giampietro Sgaragli; Gabriella Cargnelli; Sergio Bova
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 9.  Posttranslational modifications of desmin and their implication in biological processes and pathologies.

Authors:  Daniel L Winter; Denise Paulin; Mathias Mericskay; Zhenlin Li
Journal:  Histochem Cell Biol       Date:  2013-10-04       Impact factor: 4.304

10.  Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

Authors:  L Levesque; G Drapeau; J H Grose; F Rioux; F Marceau
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.